Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy

BACKGROUND: Therapeutic strategies for unresectable hepatocellular carcinoma (u‐HCC) in geriatric patients are important for real‐world practice. However, there remain no established biomarkers or therapeutic strategies regarding the best second‐line agent after atezolizumab plus bevacizumab therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekiguchi, Shuhei, Tsuchiya, Kaoru, Yasui, Yutaka, Inada, Kento, Kirino, Sakura, Yamashita, Koji, Hayakawa, Yuka, Osawa, Leona, Higuchi, Mayu, Takaura, Kenta, Maeyashiki, Chiaki, Kaneko, Shun, Tamaki, Nobuharu, Nakanishi, Hiroyuki, Itakura, Jun, Takahashi, Yuka, Asahina, Yasuhiro, Okamoto, Ryuichi, Kurosaki, Masayuki, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675392/
https://www.ncbi.nlm.nih.gov/pubmed/35302279
http://dx.doi.org/10.1002/cnr2.1613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675392/
https://www.ncbi.nlm.nih.gov/pubmed/35302279
http://dx.doi.org/10.1002/cnr2.1613

Ejemplares similares